Targretin and dyspnoea Patient Reports February 12, 2012



Targretin Side Effects Report #5756371-7
Targretin side effect was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2008. Male patient, 78 years of age, weighting 229.3 lb, was diagnosed with t-cell lymphoma and was treated with Targretin. After drug was administered, patient experienced the following side effects: cerebrovascular accident, dyspnoea, transient ischaemic attack. Targretin dosage: 525 MG, ORAL. During the same period patient was treated with ACCUPRIL, HYDROCHLOROTHIAZIDE, ZOCOR, TRICOR, OMEGA. Patient was hospitalized. Patient recovered.

Targretin Side Effects Report #5047812-1
Targretin side effect was reported by a Health Professional from UNITED STATES on July 10, 2006. Male patient, 75 years of age, weighting 141.1 lb, was diagnosed with mesothelioma What is  mesothelioma, metastasis and was treated with Targretin. After drug was administered, patient experienced the following side effects: dyspnoea, haemoptysis. Targretin dosage: 675 MG QD PO. During the same period patient was treated with DOCETAXOL, LOVENOX, LEVAQUIN. Patient was hospitalized. Patient recovered.

Targretin Side Effects Report #5032586-0
Targretin side effect was reported by a Health Professional from UNITED STATES on June 20, 2006. Male patient, 75 years of age, weighting 142.0 lb, was diagnosed with mesothelioma What is  mesothelioma and was treated with Targretin. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion, pneumonia What is  pneumonia, thrombosis. Targretin dosage: 675 MG DAILY. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Targretin Side Effects Report #5335953-0
Targretin side effect was reported by a Health Professional from UNITED STATES on July 28, 2006. Male patient, 50 years of age, weighting 192.0 lb, was diagnosed with bladder transitional cell carcinoma and was treated with Targretin. After drug was administered, patient experienced the following side effects: dyspnoea, hypotension, pulmonary hypertension What is  pulmonary hypertension. Targretin dosage: 836 MG DAILY PO. During the same period patient was treated with TAXOTERE, ATORVASTATIN CALCIUM, LEVOTHYROXINE. Patient was hospitalized. Patient died on 07/26/2006.


Targretin Side Effects Report #5080942-7
Targretin side effect was reported by a Health Professional from UNITED STATES on July 28, 2006. Male patient, 50 years of age, weighting 192.0 lb, was diagnosed with bladder cancer What is  bladder cancer and was treated with Targretin. After drug was administered, patient experienced the following side effects: chest pain What is  chest pain, dyspnoea, hypotension, hypoxia, pulmonary hypertension What is  pulmonary hypertension. Targretin dosage: 836 MG DAILY PO. During the same period patient was treated with ATORVASTATIN CALCIUM, LEVOTHYROXINE. Patient was hospitalized. Patient died on 07/26/2006.

Targretin Side Effects Report #5065902-4
Targretin side effect was reported by a Health Professional from UNITED STATES on July 28, 2006. Male patient, weighting 192.0 lb, was diagnosed with bladder cancer What is  bladder cancer and was treated with Targretin. After drug was administered, patient experienced the following side effects: blood pressure systolic increased, chest pain What is  chest pain, dyspnoea, embolism, heart rate increased, hypoxia, oxygen saturation decreased, pulmonary embolism What is  pulmonary embolism, pulmonary hypertension What is  pulmonary hypertension. Targretin dosage: 836 MG=11 TABS QD PO. During the same period patient was treated with TAXOTERE, SYNTHROID, LIPITOR. Patient was hospitalized. Patient died on 07/26/2006.

Targretin Side Effects Report #4918233-4
Targretin side effect was reported by a Physician from UNITED STATES on Jan 30, 2006. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with Targretin. After drug was administered, patient experienced the following side effects: cough, dyspnoea, dyspnoea exertional, eye haemorrhage, hypoxia, oedema, pericardial effusion, platelet count decreased, retinoic acid syndrome. Targretin dosage: 150 MG/M^2 DAILY PO. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Targretin